why choose us

🌐 Go to WebHealthNetwork.com
Go to Consumers Chat
First received: April 03, 2025

Clinical Trial: Bioequivalence Study to Compare Sacubitril and Valsartan Tablets (97mg/103mg) Versus Entresto® (Sacubitril and Valsartan) Tablets (97 mg/103 mg)

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Chronic Heart Failure

Study Type: INTERVENTIONAL


Official Title: An Open Label, Balanced, Randomized, Single Dose, Two Treatment, Two Sequence, Four Period, Full-replicate, Oral Bioequivalence Study of Sacubitril and Valsartan 97 mg/103 mg Tablets of Ç.O.S.B.,

Brief Summary: An open label, balanced, randomized, single dose, two treatment, two sequence, four period, full-replicate, oral bioequivalence Study of Sacubitril and Valsartan 97 mg/103 mg Tablets of HUMAN?S SA?LIK ANON?M ??RKET? Ç.O.S.B., Karaa?aç Mahallesi Fatih, Bulvar? No:32, Kapakl?/TEK?RDA? and Entresto® (Sacubitril and Valsartan) 97 mg/103 mg Tablets of Novartis Europharm Limited, Irija in healthy, adult, human subjects under fasting condition.

Read more